-
Agilent Technologies Inc. (NYSE:A), Santa Clara, Calif. Dako A/S, Glostrup, Denmark Business: Diagnostic, Supply/Service Agilent Technologies will acquire cancer diagnostic and tools company Dako for $2.2 billion in …
Published on 5/21/2012
-
Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Cardiovascular Astellas said its FY11 earnings ended March 31 that in March it and Pfizer extended through March 2021 from…
Published on 5/21/2012
-
Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Tsinghua University, Beijing, China Business: Cancer, Autoimmune Bristol-Myers partnered with the university to identify and validate targets in cancer and immunology,…
Published on 5/21/2012
-
Casigen Pharma Ltd., Hong Kong, China Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH), Guangzhou, China Business: Endocrine/Metabolic GIBH granted newco Casigen an exclusive, worldwide …
Published on 5/21/2012
-
Cellzome AG, Heidelberg, Germany GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Inflammation, Proteomics GlaxoSmithKline will acquire the 80.02% of proteomics company Cellzome it does not already own …
Published on 5/21/2012
-
Cornerstone Therapeutics Inc. (NASDAQ:CRTX), Cary, N.C. EKR Therapeutics Inc., Bedminster, N.J. Business: Cardiovascular Cornerstone will acquire EKR for $125 million in cash plus up to $25 million in milestones over …
Published on 5/21/2012
-
CryoLife Inc. (NYSE:CRY), Kennesaw, Ga. Hemosphere Inc., Eden Prairie, Minn. Business: Other CryoLife acquired medical device company Hemosphere for $17 million in cash, plus up to $4.5 million in milestones. The deal, …
Published on 5/21/2012
-
Evotec AG (Xetra:EVT), Hamburg, Germany IR Pharma Ltd., Kent, U.K. Business: Inflammation, Pulmonary Evotec said in its 1Q12 earnings that in February it partnered with IR Pharma to use Evotec's drug discovery platform …
Published on 5/21/2012
-
Evotec AG (Xetra:EVT), Hamburg, Germany Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Cancer Evotec said in its 1Q12 earnings that in March it extended a 2007 deal with Johnson & Johnson's Janssen …
Published on 5/21/2012
-
Fibrocell Science Inc. (OTCBB:FCSC), Exton, Pa. Massachusetts Institute of Technology, Boston, Mass. University of California, Los Angeles, Calif. Business: Gene/Cell therapy, Diagnostic Fibrocell acquired rights to …
Published on 5/21/2012
-
Human Genome Sciences Inc. (NASDAQ:HGSI), Rockville, Md. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Autoimmune, Cardiovascular, Endocrine/Metabolic Human Genome said its board unanimously …
Published on 5/21/2012
-
Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Infectious, Drug delivery, Veterinary Immunovaccine and an undisclosed company partnered to develop single dose vaccines against infectious diseases for …
Published on 5/21/2012
-
KineMed Inc., Emeryville, Calif. CHDI Foundation Inc., New York, N.Y. Business: Diagnostic KineMed partnered with the foundation to use KineMed's isotopic labeling and Dynamic Proteomics technology to investigate mutant…
Published on 5/21/2012
-
Maxygen Inc. (NASDAQ:MAXY), Redwood City, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Hematology Maxygen will receive a $30 million milestone payment from Bayer's Bayer HealthCare LLC subsidiary under a …
Published on 5/21/2012
-
Nephromics LLC, Chestnut Hill, Mass. Thermo Fisher Scientific Corp. (NYSE:TMO), Waltham, Mass. Business: Diagnostic Nephromics granted Thermo Fisher exclusive rights to use placental growth factor (PGF; PlGF) for use in…
Published on 5/21/2012
-
Neurotune AG, Schlieren, Switzerland ALS Therapy Development Institute (ALS TDI), Cambridge, Mass. Business: Neurology ALS TDI said it will evaluate the efficacy of Neurotune's TDI-165 in a preclinical model of …
Published on 5/21/2012
-
Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy Zambon Co. S.p.A., Bresso, Italy Business: Neurology Zambon exercised its option to license exclusive rights to develop and commercialize Newron's safinamide …
Published on 5/21/2012
-
Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark National Cheng Kung University, Tainan City, Taiwan Business: Autoimmune The university granted Novo Nordisk undisclosed rights to IP and technology related to an…
Published on 5/21/2012
-
Oval Medical Technologies Ltd., Cambridge, U.K. Business: Drug delivery An undisclosed pharma and Oval partnered to evaluate combining the pharma's drug with Oval's autoinjector technology. The pharma will have the …
Published on 5/21/2012
-
Pernix Therapeutics Holdings Inc. (NYSE-A:PTX), The Woodlands, Texas Seek Ltd., London, U.K. Business: Pulmonary Seek and Pernix terminated a 2010 JV to develop Pernix's BC1036 to treat persistent cough and entered into…
Published on 5/21/2012
-
Piramal Healthcare Ltd. (BSE:500302; NSE:PIRHEALTH), Mumbai, India Decision Resources Group, Burlington, Mass. Business: Other Piramal Healthcare will acquire healthcare information and analytics company Decision …
Published on 5/21/2012
-
Ruga Corp., Palo Alto, Calif. Selexagen Therapeutics Inc., San Diego, Calif. Business: Cancer Ruga acquired a RAF program from cancer company Selexagen. The program is in preclinical testing for cancers with activation …
Published on 5/21/2012
-
Scil Proteins GmbH, Halle, Germany Ono Pharmaceuticals Co. Ltd. (Tokyo:4528; Osaka:4528), Osaka, Japan Business: Pharmaceuticals Scil Proteins partnered with Ono to discover and develop therapeutics from Scil's Affilin …
Published on 5/21/2012
-
SDIX (NASDAQ:SDIX), Newark, Del. Business: Antibodies SDIX partnered with an undisclosed pharma to use SDIX's Genomic Antibody Technology to discover mAbs against a GPCR target selected by the pharma. SDIX said the …
Published on 5/21/2012
-
Sea Lane Biotechnologies LLC, Mountain View, Calif. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Antibodies Sea Lane received an undisclosed payment from Astellas' Agensys Inc. oncology affiliate under a …
Published on 5/21/2012